Lundbeck is a global pharmaceutical company that specializes in the research, development, and commercialization of therapies for brain diseases. With over 70 years of neuroscience expertise, Lundbeck has become a leader in the field, offering a range of treatments for conditions such as Alzheimer's disease, Parkinson's disease, depression, and schizophrenia.
Committed to making a difference in the lives of patients worldwide, Lundbeck focuses on supporting the person and community behind the disease. Through their sustainability strategy, they aim to mitigate business risks, reduce negative impacts, and contribute to the UN Sustainable Development Goals. With a global presence in over 100 countries and a dedicated team of 5,400 employees, Lundbeck continues to strive for breakthroughs in brain health.
Generated from the website